Literature DB >> 873130

Radioimmunoassay of bile acids: development, validation, and preliminary application of an assay for conjugates of chenodeoxycholic acid.

S W Schalm, G P van Berge-Henegouwen, A F Hofmann, A E Cowen, J Turcotte.   

Abstract

A rapid, sensitive, precise radioimmunoassay for conjugates of chenodeoxycholic (chenic) acid has been developed and validated. Immunogen was prepared with chenylglycine couples to bovine serum albumin, emulsified in Freund's complete adjuvant, and injected intracutaneously in rabbits. Antibodies of moderate titer (used at 1:7500 final dilution) were obtained. Tracer of high specific activity was prepared by reductive tritiation of delta11-chenylglycine. The binding step required 1 hr at room temperature; separation of bound tracer was achieved by addition of ammonium sulfate. The limit of sensitivity of the assay was about 20 nmoles per liter, and the lower limit of the working range was 0.4 mumole per liter. The assay was validated by measuring levels in samples of fasting state serum to which known amounts of chenylglycine had been added; the assay was also validated by means of gas-liquid chromatography on sera from jaundiced patients. The median fasting state serum level in 56 Caucasians and blacks was 0.9 mumole per liter (upper limit of normal (95% confidence) being 2.3), which is in the same range as that reported by others using gas-liquid chromatography. A 5- to 10-fold increase in levels of chenyl conjugates was observed 1 hr after the ingestion of a liquid meal in healthy persons.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 873130

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

Review 1.  Serum bile acids in hepatobiliary disease.

Authors:  I A Bouchier; C R Pennington
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

2.  Postprandial changes in serum concentrations of individual bile salts in normal subjects and patients with acute viral hepatitis.

Authors:  C B Campbell; C McGuffie; L W Powell; R K Roberts; A W Stewart
Journal:  Am J Dig Dis       Date:  1978-07

3.  Postprandial plasma concentrations of glycine and taurine conjugated bile acids in healthy subjects.

Authors:  K Linnet
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

4.  Determinants of fasting and postprandial serum bile acid levels in healthy man.

Authors:  N F LaRusso; N E Hoffman; M G Korman; A F Hofmann; A E Cowen
Journal:  Am J Dig Dis       Date:  1978-05

5.  Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.

Authors:  A F Hofmann; G Molino; M Milanese; G Belforte
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

6.  Clinical value of serum bile acid levels in chronic hepatitis.

Authors:  M B Jones; S Weinstock; R L Koretz; K J Lewin; J Higgins; G L Gitnick
Journal:  Dig Dis Sci       Date:  1981-11       Impact factor: 3.199

7.  Diagnostic value of serum immunoreactive conjugated cholic or chenodeoxycholic acids in detecting hepatobiliary diseases. Comparison with levels of 3 alpha-hydroxy bile acids determined enzymatically and with routine liver tests.

Authors:  R Ferraris; M T Fiorentini; G Galatola; P Rolfo; M De la Pierre
Journal:  Dig Dis Sci       Date:  1987-08       Impact factor: 3.199

8.  Spectrofluorimetric determination of bile acid using a europium-doxycycline probe.

Authors:  Ting Wang; Xiaolei Wang; Chongqiu Jiang
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

9.  Diurnal serum levels of primary conjugated bile acids. Assessment by specific radioimmunoassays for conjugates of cholic and chenodeoxycholic acid.

Authors:  S W Schalm; N F LaRusso; A F Hofmann; N E Hoffman; G P van Berge-Henegouwen; M G Korman
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

10.  Radioimmunoassay of primary bile salts in serum.

Authors:  Y A Baqir; J Murison; P E Ross; I A Bouchier
Journal:  J Clin Pathol       Date:  1979-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.